Holen Sie sich die Stockscreener-App
301.12
0.09%
0.16
Bio Rad Laboratories Inc Aktie (BIO) Neueste Nachrichten
In Vitro Toxicity Testing Market Set for Dynamic Growth with Key - openPR.com
Published on: 2025-12-18 13:31:33 - Улправда
Is Bio Rad Laboratories Inc. stock a safe investment in uncertain marketsJuly 2025 Rallies & Risk Controlled Daily Plans - Улправда
Published on: 2025-12-18 04:48:11 - moha.gov.vn
Multi Omics Platform Market Outlook 2025-2032: Key Trends, Size - openPR.com
DNA/RNA Extraction Kit Market to Reach US$ 5.12 Billion by 2033 - openPR.com
Fragment Analysis Market 2025-2032: Growth Overview, Facts & - openPR.com
Biodesix and Bio-Rad Laboratories Team Up on Droplet Digital PCR Assays - Medical Product Outsourcing
Is Bio-Rad (BIO) Quietly Repositioning Its Moat Around Automation‑Led Blood Diagnostics? - Sahm
IVD Diagnostic Molecule Raw Enzymes Market Forecast to Grow at 7.13% CAGR by 2034 - GlobeNewswire Inc.
MASTERINVEST Kapitalanlage GmbH Acquires New Shares in Bio-Rad Laboratories, Inc. $BIO - MarketBeat
United States DNA Sequencing Market 2031 | Growth Drivers, Key - openPR.com
Bio-Rad launches TrailBlazer Tag and TrailBlazer StarBright Dye Label Kits for antibody conjugation to StarBright Dyes - MSN
Bio-Rad Laboratories, Inc. $BIO Shares Acquired by HRT Financial LP - MarketBeat
Hound Partners LLC Has $43.91 Million Position in Bio-Rad Laboratories, Inc. $BIO - MarketBeat
Operating cash flow per share of Bio-Rad Laboratories, Inc. Class A – BER:BUWA - TradingView — Track All Markets
Improving research efficiency with high-performance flow cytometry - News-Medical
Becton Dickinson, Bio-Rad, and Thermo Fisher Propel Safety - GlobeNewswire
Becton Dickinson, Bio-Rad, and Thermo Fisher Propel Safety and Automation in Blood Collection Tubes—New Market Report Highlights $7Billion Opportunity - Yahoo Finance
Bio-Rad, Poly Medicure, and Sekisui Medical Power Rapid - GlobeNewswire
Bio-Rad, Poly Medicure, and Sekisui Medical Power Rapid Expansion in the Venous Blood Collection Market Through 2032 - Yahoo Finance
What Makes Bio-Rad Laboratories (BIO) an Investment Bet? - MSN
Ilex Capital Partners UK LLP Acquires 114,490 Shares of Bio-Rad Laboratories, Inc. $BIO - MarketBeat
United States Microfluidics Devices Market Expands Rapidly - openPR.com
Biodesix announces expanded Bio-Rad Laboratories partnership agreement to develop Droplet Digital™ PCR high complexity assays - MSN
Is Bio-Rad Laboratories, Inc. (NYSE:BIO) Potentially Undervalued? - 富途牛牛
Federated Hermes Inc. Has $30.66 Million Position in Bio-Rad Laboratories, Inc. $BIO - MarketBeat
Ariel Investments LLC Has $197.55 Million Stock Holdings in Bio-Rad Laboratories, Inc. $BIO - MarketBeat
Polymerase Chain Reaction (PCR) Market Rapid Growt 2025-2033: - openPR.com
Basic Statistics in Laboratory Quality Control - Labroots
Norges Bank Makes New Investment in Bio-Rad Laboratories, Inc. $BIO - MarketBeat
JPMorgan Chase & Co. Has $12.97 Million Stock Position in Bio-Rad Laboratories, Inc. $BIO - MarketBeat
Why (BIO) Price Action Is Critical for Tactical Trading - news.stocktradersdaily.com
Bio-Rad Laboratories, Inc. (NYSE:BIO) Given Consensus Rating of "Hold" by Analysts - MarketBeat
What is the fair value estimate for Bio Rad Laboratories Inc. (BUW) stock in 2025Market Sentiment Summary & High Conviction Buy Zone Picks - Newser
What insider purchases suggest about Bio Rad Laboratories Inc. Class stockEarnings Miss & Low Risk High Reward Ideas - Newser
How Bio Rad Laboratories Inc. (BUWA) stock performs in volatility spikesJuly 2025 Analyst Calls & Precise Buy Zone Tips - Newser
Why Bio Rad Laboratories Inc. (BUW) stock is upgraded to buyJuly 2025 EndofMonth & High Accuracy Swing Entry Alerts - Newser
Is Bio Rad Laboratories Inc. Class B stock a good hedge against inflationWeekly Risk Summary & Real-Time Chart Pattern Alerts - Newser
Why Bio Rad Laboratories Inc. (BUW) stock could break out in 2025Analyst Upgrade & Stock Market Timing Techniques - Newser
Molecular Cytogenetics Market Intelligence Report (2020-2030) Featuring Key Players Danaher, MetaSys - pharmiweb.com
Will Bio Rad Laboratories Inc. (BUWA) stock recover faster than industryTrade Entry Summary & Long-Term Safe Return Strategies - Newser
Will Bio Rad Laboratories Inc. (BUW) stock deliver compounding returnsGap Down & Weekly Watchlist for Hot Stocks - Newser
Molecular Cytogenetics Market Intelligence Report (2020-2030) Featuring Key Players Danaher, MetaSystems, Agilent Technologies, Abbott Labs, Bio-Rad Labs and MoreResearchAndMarkets.com - The AI Journal
Can Bio Rad Laboratories Inc. Class stock expand revenue streams2025 Year in Review & Weekly Top Gainers Alerts - Newser
How geopolitical risks impact Bio Rad Laboratories Inc. (BUWA) stockTrade Exit Report & Consistent Profit Trading Strategies - Newser
Why Bio Rad Laboratories Inc. stock is in analyst buy zoneEarnings Overview Summary & Low Risk High Reward Ideas - Newser
Will Bio Rad Laboratories Inc. (BUW) stock outperform energy sector in 2025Share Buyback & Free Weekly Watchlist of Top Performers - Newser
Why Bio Rad Laboratories Inc. (BUWA) stock is a must watch tickerEntry Point & Long-Term Capital Growth Strategies - Newser
Will Bio Rad Laboratories Inc. (BUW) stock recover faster than industry - Newser
Can Bio Rad Laboratories Inc. (BUWA) stock resist broad market declinesJuly 2025 Update & Weekly Stock Breakout Alerts - Newser
Circulating Biomarkers Market Projections 2025-2032: Key - openPR.com
Next Generation Sequencing Library Preparation Market - openPR.com
Hydroxyapatite Market Size, Scope 2031 by Key Companies- Zimmer - openPR.com
Fisher Asset Management LLC Sells 5,884 Shares of Bio-Rad Laboratories, Inc. $BIO - MarketBeat
Bio-Rad Laboratories (NYSE:BIO.B) Share Price Crosses Above Fifty Day Moving AverageHere's Why - MarketBeat
Will Bio Rad Laboratories Inc. Class B stock announce special dividendNew Guidance & Verified Trade Idea Suggestions - Newser
What earnings margins imply for Bio Rad Laboratories Inc. Class B stockMarket Risk Report & Verified Technical Trade Signals - Newser
Bio-Rad Laboratories (NYSE: BIO) insider files to sell 776 shares under Rule 144 - Stock Titan
Bio-Rad Laboratories, Inc. $BIO Position Trimmed by Legal & General Group Plc - MarketBeat
Rhumbline Advisers Has $12.10 Million Stock Position in Bio-Rad Laboratories, Inc. $BIO - MarketBeat
Why analysts maintain buy rating on Bio Rad Laboratories Inc. (BUW) stockJuly 2025 PostEarnings & Real-Time Buy Zone Alerts - Newser
1.71%
0.08%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):